Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Pharmaceutical companies could serve their own interests by supporting research on the efficacy of psychotherapy on premature ejaculation

International Journal of Impotence Research volume 20, pages 115–120 (2008)Cite this article

Abstract

For many men, the treatment of sexual dysfunctions such as premature ejaculation may well be most effective when pharmacotherapy is combined with psychotherapy. Yet the essential elements of psychotherapy that might best be combined with pharmacological-based therapy are currently unknown. Support for evidence-based studies that identify key components of psychotherapy that might improve positive long-term outcomes, including patient satisfaction, are needed. Pharmaceutical companies having a vested interest in achieving both treatment adherence and improved patient outcomes could benefit from such information.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Masters WH, Johnson VE . Human Sexual Inadequacy. Little, Brown & Co: Boston, 1970.

    Google Scholar 

  2. Kaplan HS . The New Sex Therapy. Brunner/Mazel: New York, 1974.

    Google Scholar 

  3. Heiman JR, Meston C . Empirically validated treatment for sexual dysfunction. Annu Rev Sex Res 1997; 8: 148–194.

    CAS  PubMed  Google Scholar 

  4. Rowland DL, Cooper SE, Slob AK . The treatment of premature ejaculation: psychological and biological strategies. Drugs Today 1998; 34: 879–899.

    Article  CAS  Google Scholar 

  5. DeAmicis LA, Goldberg DC, LoPiccolo J, Friedman J, Davies L . Clinical follow-up of couples treated for sexual dysfunction. Arch Sex Behav 1985; 14: 467–489.

    Article  CAS  Google Scholar 

  6. Heiman JR, LoPiccolo J . Clinical outcome of sex therapy. Arch Gen Psychiatry 1983; 40: 443–449.

    Article  CAS  Google Scholar 

  7. Hawton K, Catalan J, Martin P, Fagg J . Long-term outcome of sex therapy. Behav Res Ther 1986; 24: 665–675.

    Article  CAS  Google Scholar 

  8. Hawton K . Sex therapy research: Has it withered on the vine? Annu Rev Sex Res 1992; 3: 49–72.

    Article  Google Scholar 

  9. Schover LR, Leiblum SR . Commentary: the stagnation of sex therapy. J Psychol Hum Sex 1994; 6: 5–30.

    Article  Google Scholar 

  10. Perelman MA . A new combination treatment for premature ejaculation: a sex therapist's perspective. J Sex Med 2006. doi: 10.1111/j.1743-6109.2006.00238.x.

    Article  Google Scholar 

  11. American Psychological Association. American Psychological Association statement policy on evidence-based practice in psychology. Retrieved 1 September, 2005 from http://www.apa.org/practice/ebpreport.pdf.

  12. McMahon CG, Abdo C, Incrocci L, Perelman M, Rowland D, Waldinger M et al. Disorders of orgasm and ejaculation in men. J Sex Med 2004; 1: 58–65.

    Article  Google Scholar 

  13. Waldinger M . The neurobiological approach to premature ejaculation. J Urol 2002; 168: 2359–2367.

    Article  Google Scholar 

  14. Althof SE . Therapeutic weaving: the integration of treatment techniques. In: Levine SB, Risen CB, Althof SE, (eds). Handbook of Clinical Sexuality for Mental Health Professionals. Brunner-Routledge: New York, 2003, pp 359–376.

    Google Scholar 

  15. Barada JH . Optimizing outcomes of oral therapy for patients with erectile dysfunction. Rev Urol 2003; 5: S28–S34.

    PubMed  PubMed Central  Google Scholar 

  16. Althof SE . Sexual therapy in the age of pharmacotherapy. Annu Rev Sex Res 2006; 17: 116–131.

    Google Scholar 

  17. Rowland DL, Cooper SE . Behavioral and psychological models in ejaculatory function research. Curr Sex Health Rep 2005; 2: 29–34.

    Article  Google Scholar 

  18. Althof SE . Psychological treatment strategies for rapid ejaculation: rationale, practical aspects, and outcome. World J Urol 2005; 23: 89–92.

    Article  Google Scholar 

  19. American Psychological Association. Empirically supported therapy relationships: conclusions and recommendations of the division 29 task force. Psychotherapy: Theory Res Pract Train 2001; 38: 495–497.

    Article  Google Scholar 

  20. Straub RL . Health Psychology 2nd edn. Worth Publishers: New York, 2007, pp 375–383.

    Google Scholar 

  21. Rowland DL, Tai WL, Slob AK . Predicting responsiveness to the treatment of rapid ejaculation with 25 mg clomipramine as needed. Int J Impot Res 2004; 16: 354–357.

    Article  CAS  Google Scholar 

  22. Norcross JC (ed). Psychotherapy Relationships That Work: Therapist Contributions and Their Responsiveness to Patient Needs. Oxford University Press: New York, 2002, pp 3–16.

    Google Scholar 

  23. Kazdin AE . Treatment outcomes, common factors, and continued neglect of mechanisms of change. Clin Psychol Sci Prac 2005; 12: 184–188.

    Article  Google Scholar 

  24. Nathan PE, Gorman JM . A Guide to Treatments that Work 2nd edn. Oxford University Press: New York, 2002, pp 497–525.

    Google Scholar 

  25. Wampold BE, Bhati KS . Attending to the omissions: a historical examination of evidence-based practice movements. Prof Psychol Res Prac 2004; 35: 563–570.

    Article  Google Scholar 

  26. Bohart AC, Tallman K . How Clients make Therapy Work: The Process of Active Self-Healing. American Psychological Association: Washington, DC, 1999.

    Book  Google Scholar 

  27. Pfizer. Pfizer: Who we are: Public policy. Retrieved 2 January, 2006 from http://www.pfizer.com/pfizer/are/about_public/mn_about_clemente_article_medicare.jsp.

  28. Miller KL . The Pill Machine. Newsweek (Atlantic Edn); 2001; 138: 44.

    Google Scholar 

  29. West D . Doing well by doing good. Pharmaceut Exec 2000; 20: 98.

    Google Scholar 

  30. Poor market. rich rewards. Economist 2004; 372: 65–66.

    Google Scholar 

  31. GlaxoSmithKline. GlaxoSmithKline: About GSK: The Company: The Spirit of GSK. Retrieved 2 January, 2006 from http://gsk.co.nz/about.asp?pageID=466.

Download references

Author information

Authors and Affiliations

  1. Department of Psychology, Valparaiso University, 1001 Campus Drive South, Valparaiso, IN, USA

    D Rowland, S Cooper & L Macias

Authors
  1. D Rowland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Macias
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D Rowland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rowland, D., Cooper, S. & Macias, L. Pharmaceutical companies could serve their own interests by supporting research on the efficacy of psychotherapy on premature ejaculation. Int J Impot Res 20, 115–120 (2008). https://doi.org/10.1038/sj.ijir.3901559

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901559

This article is cited by

Search

Advanced search

Quick links